Characterization of Human Milk Oligosaccharides From Chinese Mothers and Their Association with Delivery Mode and Infant Eczema

Why It Matters

The findings reveal that delivery mode can alter the bioactive composition of breast milk, potentially influencing infant immune development and allergy risk, highlighting a new dimension for post‑natal care strategies.

Key Takeaways

• C‑section delivery linked to lower levels of 2’FL, LNnT, and LNFP‑III
• Five HMO clusters identified, reflecting fucosylation and sialylation patterns
• Higher LSTb in mature milk (>90 days) modestly reduces infant eczema risk
• HMOs generally decline over lactation except 3‑FL, which rises sharply
• Study spans 635 Chinese mother‑infant pairs across eight provinces

Pulse Analysis

Human milk oligosaccharides (HMOs) are a cornerstone of infant nutrition, shaping gut microbiota and modulating immune responses. While the overall HMO profile is largely dictated by maternal genetics—particularly FUT2 and FUT3 secretor status—environmental and physiological factors also play a role. Recent large‑scale analyses across diverse populations have confirmed that most HMOs peak in colostrum and gradually wane, with the notable exception of 3‑FL, which increases as lactation progresses. These dynamic patterns underscore the importance of timing when evaluating milk bioactives for infant health outcomes.

The new Chinese cohort adds a critical layer to the emerging narrative that delivery mode influences milk composition. Cesarean sections were associated with reduced concentrations of several α‑1,2‑fucosylated HMOs such as 2’FL and LNFP‑III, especially in the first three weeks postpartum. Potential mechanisms include surgery‑related inflammation, altered hormonal cascades, and delayed onset of lactogenesis, all of which could suppress glycosyltransferase activity responsible for HMO synthesis. This aligns with prior reports from Europe and Asia, though the magnitude of reduction varies by region and by whether the C‑section was elective or emergency, a nuance not captured in the current dataset.

From a clinical perspective, the modest protective link between higher LSTb levels in mature milk and reduced infant eczema offers a tangible target for nutritional interventions. While the effect size is small, it suggests that augmenting specific sialylated HMOs—through maternal diet, probiotic supplementation, or even synthetic HMO additives—could become part of a broader strategy to curb early‑life allergic disease. Future research should integrate maternal and infant genomics, microbiome profiling, and longitudinal health tracking to unravel the causal pathways connecting delivery mode, HMO composition, and long‑term immune health.